EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

Dickson, R. (Rumona), Boland, A. (Angela), Duarte, R. (Rui), Kotas, E. (Eleanor), Woolacott, N. (Nerys), Hodgson, R. (Robert), R. Riemsma (Rob), Grimm, S. (Sabine), B.L.T. Ramaekers (Bram), M.A. Joore (Manuela), et al. Brazzelli, M. (Miriam)

2018-05-28

Additional Metadata
Persistent URL	doi.org/10.1007/s40258-018-0393-7, hdl.handle.net/1765/107179
Journal	Applied Health Economics and Health Policy
Organisation	Institute for Medical Technology Assessment (iMTA)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Dickson, R. (Rumona), Boland, A. (Angela), Duarte, R. (Rui), Kotas, E. (Eleanor), Woolacott, N. (Nerys), Hodgson, R. (Robert), … Brazzelli, M. (Miriam). (2018). EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. Applied Health Economics and Health Policy, 1–4. doi:10.1007/s40258-018-0393-7

Publication